四肢静脉畸形硬化治疗术后病灶体积与信号变化的整体病灶评估
本研究对81例四肢静脉畸形患者的125次经皮硬化治疗进行前后T2加权MRI病灶整体分割,量化病灶体积与信号强度变化。治疗成功77例(95%),病灶体积平均减少7.9±24 cm³、信号强度平均降低123±162(均P<.001),成功组体积减少大于失败组。病灶体积变化是治疗反应的可靠指标,体积与信号变化在特定亚组中与临床结局相关。
要点
- 治疗成功组病灶体积平均减少9.4±24 cm³,失败组平均增加21±20 cm³(P=.006)。
- 病灶体积变化与治疗反应相关(ρ=-0.3,P=.004),可作为治疗反应的可靠指标。
- 信号强度变化仅在单次治疗和博来霉素治疗亚组中与临床结局相关。
核心结论
- 病灶体积变化是治疗反应的可靠指标,病灶体积与信号强度变化在特定亚组中与临床结局相关。
研究设计与样本
- 回顾性分析81例四肢静脉畸形患者共125次经皮硬化治疗,在治疗前后T2加权MRI上使用3D Slicer手动分割病灶,评估病灶体积和信号强度变化。
- 临床结局按患者对症状改善感知的7点Likert量表评分,据此判定治疗成功或失败。
关键影像表现/征象
- 治疗前后T2加权MRI上手动分割病灶,评估病灶体积和信号强度变化。
诊断标准与关键数值
- 治疗成功77例(95%),失败4例(5%)。
- 病灶体积平均变化-7.9±24 cm³,信号强度平均变化-123±162(均P<.001)。
- 成功组病灶体积平均减少9.4±24 cm³,失败组平均增加21±20 cm³(P=.006)。
- 病灶体积与治疗反应相关(ρ=-0.3,P=.004);儿童亚组ρ=-0.3(P=.03),十四烷基硫酸钠治疗病灶ρ=-0.5(P=.02),足部病灶ρ=-0.6(P=.04)。
- 信号强度变化与临床结局在单次经皮硬化治疗病灶(ρ=-0.3,P=.01)和博来霉素治疗病灶(ρ=-0.4,P=.04)中相关。
临床应用与阅片要点
- 作者认为病灶体积变化是治疗反应的可靠指标,病灶体积和信号强度变化在特定亚组中与临床结局相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate quantitative changes in MRI signal intensity (SI) and lesion volume that indicate treatment response and correlate these changes with clinical outcomes after percutaneous sclerotherapy (PS) of extremity venous malformations (VMs).
METHODS: VMs were segmented manually on pre- and post-treatment T2-weighted MRI using 3D Slicer to assess changes in lesion volume and SI. Clinical outcomes were scored on a 7-point Likert scale according to patient perception of symptom improvement; treatment response (success or failure) was determined accordingly.
RESULTS: Eighty-one patients with VMs underwent 125 PS sessions. Treatment success occurred in 77 patients (95 %). Mean (±SD) changes were -7.9 ± 24 cm3 in lesion volume and -123 ± 162 in SI (both, P <.001). Mean reduction in lesion volume was greater in the success group (-9.4 ± 24 cm3) than in the failure group (21 ± 20 cm3) (P =.006). Overall, lesion volume correlated with treatment response (ρ = -0.3, P =.004). On subgroup analysis, volume change correlated with clinical outcomes in children (ρ = -0.3, P =.03), in sodium tetradecyl sulfate-treated lesions (ρ = -0.5, P =.02), and in foot lesions (ρ = -0.6, P =.04). SI change correlated with clinical outcomes in VMs treated in 1 PS session (ρ = -0.3, P =.01) and in bleomycin-treated lesions (ρ = -0.4, P =.04).
CONCLUSIONS: Change in lesion volume is a reliable indicator of treatment response. Lesion volume and SI correlate with clinical outcomes in specific subgroups.
引用
- Khalil A, Laguna A, I Mehta T, et al. Whole-lesion assessment of volume and signal changes after sclerotherapy of extremity venous malformations. Eur J Radiol. 2024. PMID: 38452733. doi:10.1016/j.ejrad.2024.111397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。